The association between food insecurity and mortality among HIV-infected individuals on HAART

Journal of Acquired Immune Deficiency Syndromes

Volumn 52, Issue 3, 2009, Pages 342-349

  Weiser, Sheri D ^a   Fernandes, Kimberly A ^b   Brandson, Eirikka K ^b   Lima, Viviane D ^b,c   Anema, Aranka ^b   Bangsberg, David R ^d   Montaner, Julio S ^b,c   Hogg, Robert S ^b,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e SIMON FRASER UNIVERSITY   (Canada)

Author keywords

Food insecurity; HIV AIDS; Mortality; Vancouver

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BODY MASS; CANADA; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; FOLLOW UP; FOOD SECURITY; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIOECONOMICS; UNDERWEIGHT;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRITISH COLUMBIA; FEMALE; FOOD SUPPLY; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; POVERTY; RISK FACTORS; THINNESS;

EID: 70350521741     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181b627c2     Document Type: Article

References (68)

1. Hogg RS, O'Shaughnessy MV, Gataric N, et al. Decline in deaths from AIDS due to new antiretrovirals. Lancet. 1997;349:1294.
2. Hogg RS, Yip B, Chan KJ, et al Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA. 2001;286:2568-2577.
3. Hogg R, Lima V, Sterne JA, et al. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293-299.
4. Jain S, Schwarcz S, Katz M, et al. Elevated risk of death for African Americans with AIDS, San Francisco, 1996-2002. J Health Care Poor Underserved. 2006;17:493-503.
5. Tegger MK, Crane HM, Tapia KA, et al. The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals. AIDS Patient Care STDS. 2008;22:233-243.
6. Tucker JS, Burnam MA, Sherbourne CD, et al. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114:573-580.
7. Weiser SD, Wolfe WR, Bangsberg DR. The HIV epidemic among individuals with mental illness in the United States. Curr Infect Dis Rep. 2004;6:404-410.
8. Leaver CA, Bargh G, Dunn JR, et al. The effects of housing status on health-related outcomes in people living with HIV: a systematic review of the literature. AIDS Behav. 2007;11(Suppl 6):85-100.
9. McFarland W, Chen S, Hsu L, et al. Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco. J Acquir Immune Defic Syndr. 2003; 33:96-103.
10. Wood E, Kerr T, Palepu A, et al. Slower uptake of HIV antire-troviral therapy among aboriginal injection drug users. J Infect. 2006;52: 233-236.
11. Miller CL, Spittal PM, Wood E, et al. Inadequacies in antiretroviral therapy use among aboriginal and other Canadian populations. AIDS Care. 2006;18:968-976.
12. Miller CL, Kerr T, Strathdee SA, et al. Factors associated with premature mortality among young injection drug users in Vancouver. Harm Reduct J. 2007;4:1.
13. Lima VD, Kretz P, Palepu A, et al. Aboriginal status is a prognostic factor for mortality among antiretroviral naive HIV-positive individuals first initiating HAART. AIDS Res Ther. 2006;3:14.
14. Spittal PM, Hogg RS, Li K, et al. Drastic elevations in mortality among female injection drug users in a Canadian setting. AIDS Care. 2006;18: 101-108.
15. Joy R, Druyts EF, Brandson EK, et al. Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr. 2008;47:500-505.
16. Normen L, Chan K, Braitstein P, et al. Food insecurity and hunger are prevalent among HIV-positive individuals in British Columbia, Canada. J Nutr. 2005;135:820-825.
17. Siefert K, Heflin CM, Corcoran ME, et al. Food insufficiency and physical and mental health in a longitudinal survey of welfare recipients. J Health Soc Behav. 2004;45:171-186.
18. Heflin CM, Siefert K, Williams DR. Food insufficiency and women's mental health: findings from a 3-year panel of welfare recipients. Soc Sci Med. 2005;61:1971-1982.
19. Che J, Chen J. Food insecurity in Canadian households. Health Rep. 2001; 12:11-22.
20. Alaimo K, Olson CM, Frongillo EA. Family food insufficiency, but not low family income, is positively associated with dysthymia and suicide symptoms in adolescents. J Nutr. 2002;132:719-725.
21. Seligman HK, Bindman AB, Vittinghoff E, et al. Food insecurity is associated with diabetes mellitus: results from the National Health Examination and Nutrition Examination Survey (NHANES) 1999-2002. J Gen Intern Med. 2007;22:1018-1023.
22. Vozoris NT, Tarasuk VS. Household food insufficiency is associated with poorer health. J Nutr. 2003;133:120-126.
23. Kushel MB, Gupta R, Gee L, et al. Housing instability and food insecurity as barriers to health care among low-income Americans. J Gen Intern Med. 2006;21:71-77.
24. Kersey MA, Beran MS, McGovern PG, et al. The prevalence and effects of hunger in an emergency department patient population. Acad Emerg Med. 1999;6:1109-1114.
25. Gillespie S, Kadiyala S. HIV/AIDS and food and nutrition security: from evidence to action. Available at: http://www.ifpri.org/pubs/fpreview/pv07/ pv07.pdf. Accessed September 23, 2008.
26. Castleman T, Seumo-Fosso E, Cogill B. Food and nutrition implications of antiretroviral therapy in resource limited settings. Available at: http:// www.fantaproject.org/downloads/pdfs/tn7-ARVs.pdf. Accessed September 23, 2008.
27. Weiser SD, Frongillo EA, Ragland K, et al. Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San Francisco. J Gen Intern Med. 2009;1:14-20.
28. Kendall A, Olson CM, Frongillo EA Jr. Validation of the Radimer/Cornell measures of hunger and food insecurity. J Nutr. 1995;125:2793-2801.
29. Radimer KL, Olson CM, Campbell CC. Development of indicators to assess hunger. J Nutr. 1990;120(Suppl 11):1544-1548.
30. Ferro-Luzzi A, Sette S, Franklin M, et al. A simplified approach of assessing adult chronic energy deficiency. Eur J Clin Nutr. 1992;46: 173-186.
31. James WP, Ferro-Luzzi A, Waterlow JC. Definition of chronic energy deficiency in adults. Report of a working party of the International Dietary Energy Consultative Group. Eur J Clin Nutr. 1988;42:969-981.
32. Low-Beer S, Yip B, O'Shaughnessy MV, et al. Adherence to triple therapy and viral load response. J Acquir Immune Defic Syndr. 2000;23: 360-361.
33. Lima VD, Geller J, Bangsberg DR, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS. 2007;21:1175-1183.
34. Hogg RS, Heath K, Bangsberg D, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002;16:1051-1058.
35. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993;138:923-936.
36. Lima VD, Geller J, Bangsberg DR, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS Care. 2007;21:1175-1183.
37. Wood E, Hogg RS, Lima VD, et al. Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA. 2008;300: 550-554.
38. Dietz PM, Spitz AM, Anda RF, et al. Unintended pregnancy among adult women exposed to abuse or household dysfunction during their childhood. JAMA. 1999;282:1359-1364.
39. Kotler DP, Tierney AR, Wang J, et al. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr. 1989;50:444-447.
40. Wheeler DA, Gibert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:80-85.
41. van der Sande MA, van der Loeff MF, Aveika AA, et al. Body mass index at time of HIV diagnosis: a strong and independent predictor of survival. J Acquir Immune Defic Syndr. 2004;37:1288-1294.
42. Guenter P, Muurahainen N, Simons G, et al. Relationships among nutritional status, disease progression, and survival in HIV infection. J Acquir Immune Defic Syndr. 1993;6:1130-1138.
43. Chlebowski RT, Grosvenor MB, Bernhard NH, et al. Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS. Am J Gastroenterol. 1989;84:1288-1293.
44. Tang AM, Forrester J, Spiegelman D, et al. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31:230-236.
45. Zachariah R, Fitzgerald M, Massaquoi M, et al. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS. 2006;20:2355-2360.
46. Anastos A, Shi Q, Lu D, et al. Association of pre-treatment nutritional status with CD4 and viral load response to ART in Rwandan women. Paper presented at: 15th Conference on Retroviruses and Opportunistic Infections; February 3-6, 2008; Boston, MA.
47. May M, Boulle A, Messou E, et al. Mortality of HIV-1-infected patients starting ART in sub-Saharan Africa: the IeDEA prognostic model. Paper presented at: 15th Conference on Retroviruses and Opportunistic Infections; February 3-6, 2008; Boston, MA.
48. Programming in the Era of AIDS: WPF's Response to HIV/AIDS. Available at: http://reliefweb.int/rw/lib.nsf/db900sid/PANA-7DSFKW/ $file/wfp-jan2003. pdf?openelement. Accessed September 23, 2008.
49. World Health Organization. Nutrient Requirements for People Living with HIV/AIDS: Report of a Technical Consultation. Available at: http:// www.who.int/nutrition/publications/Content-nutrient-requirements.pdf. Accessed September 23, 2008.
50. Seume-Fosso E, Rajabiun S, Cogill B, et al. Food and nutrition technical assistance. HIV/AIDS: a guide for nutritional care and support. October 2004; Available at: http://www.fantaproject.org/publications/HIVguide. shtml. Accessed September 23, 2008.
51. Chlebowski RT, Grosvenor M, Lillington L, et al. Dietary intake and counseling, weight maintenance, and the course of HIV infection. J Am Diet Assoc. 1995;95:428-432; Quiz 433-1425
52. Macallan DC, Noble C, Baldwin C, et al. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med. 1995;333: 83-88.
53. Jones CY, Hogan JW, Snyder B, et al. Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis. 2003;37(Suppl 2):S69-S80.
54. Calmy A, Pinoges L, Szumilin E, et al. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS. 2006;20:1163-1169.
55. Melchior JC, Niyongabo T, Henzel D, et al. Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients. Nutrition. 1999;15:865-869.
56. Lindan CP, Allen S, Serufilira A, et al. Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med. 1992;116: 320-328.
57. Batterham MJ, Garsia R, Greenop P. Prevalence and predictors of HIV-associated weight loss in the era of highly active antiretroviral therapy. Int J STD AIDS. 2002;13:744-747.
58. Campa A, Yang Z, Lai S, et al. HIV-related wasting in HIV-infected drug users in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;41:1179-1185.
59. Gustavson L, Lam W, Bertz R, et al. Assessment of the bioequivalence and food effects for liquid and soft gelatin capsule co-formulations of ABT-378/ritonavir (ABT-378/r) in healthy subjects. Paper presented at: 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20, 2000; Toronto, Canada.
60. Bardsley-Elliot A, Plosker GL. Nelfinavir: an update on its use in HIV infection. Drugs. 2000;59:581-620.
61. Abbot Laboratories. Kaletra [package insert]. Available at: http://www. fda.gov/cder/foi/label/ 2005/021226s016lbl.pdf. Accessed November 14, 2007.
62. Nachega JB, Knowlton AR, Deluca A, et al. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. J Acquir Immune Defic Syndr. 2006;43(Suppl 1): S127-S133.
63. Au JT, Kayitenkore K, Shutes E, et al. Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV-infected individuals in Rwanda. AIDS. 2006;20:2116-2118.
64. Hardon AP, Akurut D, Comoro C, et al. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19:658-665.
65. Peretti-Watel P, Spire B, Schiltz MA, et al. Vulnerability, unsafe sex and non-adherence to HAART: evidence from a large sample of French HIV/ AIDS outpatients. Soc Sci Med. 2006;62:2420-2433.
66. Farmer P, Robin S, Ramilus SL, Kim JY. Tuberculosis, poverty, and ''compliance'': lessons from rural Haiti. Semin Respir Infect. 1991;6: 254-260.
67. Baldwin MR, Yori PP, Ford C, et al. Tuberculosis and nutrition: disease perceptions and health seeking behavior of household contacts in the Peruvian Amazon. Int J Tuberc Lung Dis. 2004;8:1484-1491.
68. Ickovics J, Hamburger M, Vlahov D, et al. Mortality, CD4 count decline and depressive symptoms among HIV-seropositive women. Longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285: 1466-1474.